目前肺静脉隔离射频消融治疗房颤用于治疗复发性有症状的或对抗心律失常药物不敏感的房颤患者。
At present, pulmonary vein isolation with catheter ablation is an effective treatment in patients with symptomatic atrial fibrillation refractory or intolerant to anti-arrhythmic medications.
在肺静脉隔离组，88%的患者服用了抗心律失常药物，没有服用抗心律失常药的患者中的71%，在其后6个月没有发生房颤。
Eighty-eight per cent of patients receiving antiarrhythmic drugs in the PVI group, and 71% not receiving these agents, were free of atrial fibrillation at 6 months.
节段性肺静脉电隔离术后心房颤动复发率较高， 限制了该项技术的临床应用，现对其复发的原因与机制作一综述。
The high recurrence of atrial fibrillation after segmental pulmonary vein isolation inhibits this techniques clinical application and the mechanisms and causes of which were reviewed in the text.
结论：电学隔离肺静脉治疗AF是可行的，形成确切的连续透壁肺静脉损伤可简化消融治疗AF的径线。
Conclusion: Pulmonary veins isolation is an feasible treatment for AF. Ablation linear for the treatment of AF can be simplified if continuous and transmural lesion were produced.
本研究提示阵发性房颤患者的首选消融策略为肺静脉前庭隔离术，而不是碎裂电位消融术。
However, no randomized study comparing the clinical efficacy of PV antrum isolation ablation versus CFEs ablation as a primary strategy in patients with paroxysmal AF has been performed.
本研究提示阵发性房颤患者的首选消融策略为肺静脉前庭隔离术，而不是碎裂电位消融术。
However, no randomized study comparing the clinical efficacy of PV antrum isolation ablation versus CFEs ablation as a primary strategy in patients with paroxysmal AF has been performed.
应用推荐